MedPath

Episurf Medical Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:1
Completed:1

Trial Phases

1 Phases

Not Applicable:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Not Applicable
2 (100.0%)

Clinical Investigation on the Outcome of Episealer Talus Post-operation for Treatment of Focal Osteochondral Defects

Recruiting
Conditions
Osteochondral Defect
First Posted Date
2024-01-26
Last Posted Date
2024-01-26
Lead Sponsor
Episurf Medical Inc.
Target Recruit Count
25
Registration Number
NCT06225674
Locations
🇩🇪

Robert-Koch-Krankenhaus Apolda, Apolda, Germany

🇩🇪

OrthoCentrum Hamburg, Hamburg, Germany

🇩🇪

St. Elisabeth-Krankenhaus, Salzgitter, Germany

and more 3 locations

Episealer® Knee System IDE Clinical Study

Not Applicable
Active, not recruiting
Conditions
Degenerative Lesion of Articular Cartilage of Knee
First Posted Date
2019-06-27
Last Posted Date
2024-07-30
Lead Sponsor
Episurf Medical Inc.
Target Recruit Count
13
Registration Number
NCT04000659
Locations
🇺🇸

Physicians Research Group, Tempe, Arizona, United States

🇺🇸

Horizon Clinical Research, La Mesa, California, United States

🇺🇸

Ochsner Sports Medicine Institute, New Orleans, Louisiana, United States

and more 10 locations

Investigation of a Customized Femoral Resurfacing Implant

Not Applicable
Completed
Conditions
Articular Cartilage Disorder
First Posted Date
2012-09-24
Last Posted Date
2020-12-17
Lead Sponsor
Episurf Medical Inc.
Target Recruit Count
10
Registration Number
NCT01690689
Locations
🇸🇪

Lund University Hospital, Department of Ortopedics, Lund, Sweden

🇸🇪

Aleris Specialistvård, Stockholm, Sweden

🇸🇪

Sports Medicine Umeå, Umeå, Sweden

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.